Tilray Brands, Inc. (TLRY)
NASDAQ: TLRY · Real-Time Price · USD
6.32
-0.22 (-3.36%)
At close: Mar 27, 2026, 4:00 PM EDT
6.33
+0.01 (0.12%)
After-hours: Mar 27, 2026, 7:59 PM EDT
Tilray Brands Market Cap
Tilray Brands has a market cap or net worth of $736.32 million as of March 27, 2026. Its market cap has increased by 33.30% in one year.
Market Cap
736.32M
Enterprise Value
764.40M
1-Year Change
33.30%
Ranking
Category
Stock Price
$6.32
Market Cap Chart
Since May 4, 2021, Tilray Brands's market cap has decreased from $9.87B to $736.32M, a decrease of -92.54%. That is a compound annual growth rate of -41.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 736.32M | -29.51% |
| Dec 31, 2025 | 1.04B | -13.05% |
| Dec 31, 2024 | 1.20B | -28.47% |
| Dec 29, 2023 | 1.68B | 2.13% |
| Dec 30, 2022 | 1.64B | -63.52% |
| Dec 31, 2021 | 4.51B | -54.31% |
| May 4, 2021 | 9.87B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Collegium Pharmaceutical | 1.03B |
| Pacira BioSciences | 984.33M |
| Alvotech | 973.49M |
| Cronos Group | 950.89M |
| Amphastar Pharmaceuticals | 862.49M |
| Evotec SE | 859.36M |
| BioAge Labs | 716.73M |
| Esperion Therapeutics | 703.66M |